Jessica Jones-Carson
Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nitric Oxide | 16 | 2020 | 892 | 2.300 |
Why?
| Salmonella typhimurium | 14 | 2018 | 174 | 1.380 |
Why?
| Salmonella | 4 | 2020 | 54 | 1.160 |
Why?
| Burkholderia pseudomallei | 3 | 2014 | 10 | 1.030 |
Why?
| Salmonella enterica | 5 | 2016 | 53 | 0.940 |
Why?
| Bacterial Proteins | 16 | 2020 | 759 | 0.900 |
Why?
| Bacillus subtilis | 1 | 2020 | 61 | 0.710 |
Why?
| Cytokinesis | 1 | 2020 | 46 | 0.710 |
Why?
| Cytochrome d Group | 1 | 2016 | 2 | 0.600 |
Why?
| Cytochrome b Group | 1 | 2016 | 15 | 0.600 |
Why?
| Candidiasis | 8 | 2000 | 59 | 0.550 |
Why?
| Escherichia coli | 1 | 2020 | 758 | 0.540 |
Why?
| Macrophages | 7 | 2014 | 1324 | 0.540 |
Why?
| Anti-Bacterial Agents | 3 | 2014 | 1510 | 0.520 |
Why?
| Interferon-gamma | 8 | 2014 | 736 | 0.520 |
Why?
| Imipenem | 1 | 2014 | 17 | 0.510 |
Why?
| Oxygen | 2 | 2016 | 854 | 0.480 |
Why?
| Candida albicans | 7 | 2000 | 58 | 0.460 |
Why?
| Salmonella Infections | 4 | 2013 | 51 | 0.440 |
Why?
| Burkholderia mallei | 2 | 2011 | 7 | 0.430 |
Why?
| Gene Expression Regulation, Bacterial | 5 | 2018 | 279 | 0.420 |
Why?
| Energy Metabolism | 1 | 2016 | 767 | 0.400 |
Why?
| Iron-Sulfur Proteins | 2 | 2008 | 26 | 0.390 |
Why?
| Immunologic Memory | 2 | 2007 | 313 | 0.380 |
Why?
| Macrophages, Peritoneal | 10 | 2011 | 96 | 0.350 |
Why?
| Phagosomes | 4 | 2020 | 43 | 0.340 |
Why?
| Gastric Mucosa | 2 | 2007 | 45 | 0.330 |
Why?
| Mice | 39 | 2020 | 15520 | 0.320 |
Why?
| Proton-Motive Force | 2 | 2020 | 6 | 0.310 |
Why?
| Oxygen Consumption | 2 | 2020 | 586 | 0.270 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2005 | 310 | 0.270 |
Why?
| Animals | 40 | 2020 | 33381 | 0.260 |
Why?
| T-Lymphocytes | 4 | 2004 | 1774 | 0.250 |
Why?
| Salmonella Infections, Animal | 7 | 2010 | 38 | 0.250 |
Why?
| Endotoxemia | 1 | 2005 | 93 | 0.250 |
Why?
| Repressor Proteins | 3 | 2013 | 377 | 0.250 |
Why?
| Membrane Proteins | 3 | 2007 | 1055 | 0.250 |
Why?
| Mice, Inbred C57BL | 18 | 2018 | 4908 | 0.240 |
Why?
| Immunity, Innate | 8 | 2020 | 745 | 0.240 |
Why?
| Mice, Knockout | 13 | 2008 | 2680 | 0.230 |
Why?
| Shock, Septic | 1 | 2005 | 187 | 0.230 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2005 | 359 | 0.210 |
Why?
| Guanosine Tetraphosphate | 2 | 2020 | 4 | 0.210 |
Why?
| Immunocompromised Host | 3 | 1999 | 200 | 0.210 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2007 | 702 | 0.210 |
Why?
| NADPH Oxidases | 5 | 2008 | 138 | 0.200 |
Why?
| Genomic Islands | 2 | 2018 | 8 | 0.190 |
Why?
| Aconitate Hydratase | 2 | 2012 | 17 | 0.190 |
Why?
| T-Lymphocyte Subsets | 3 | 2000 | 396 | 0.180 |
Why?
| Ligases | 1 | 2020 | 32 | 0.180 |
Why?
| Pyrophosphatases | 1 | 2020 | 22 | 0.180 |
Why?
| Cytoskeletal Proteins | 1 | 2020 | 146 | 0.170 |
Why?
| Electron Transport Chain Complex Proteins | 2 | 2016 | 18 | 0.170 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 1999 | 102 | 0.170 |
Why?
| Stress, Physiological | 3 | 2018 | 415 | 0.170 |
Why?
| Immunity, Mucosal | 3 | 2004 | 86 | 0.170 |
Why?
| Virulence Factors | 3 | 2018 | 140 | 0.160 |
Why?
| Nitrosative Stress | 1 | 2018 | 4 | 0.160 |
Why?
| Escherichia coli Infections | 1 | 1999 | 105 | 0.160 |
Why?
| Oxidation-Reduction | 3 | 2016 | 940 | 0.160 |
Why?
| Immunologic Deficiency Syndromes | 2 | 1995 | 75 | 0.160 |
Why?
| Microbial Viability | 4 | 2018 | 81 | 0.160 |
Why?
| Oxidative Stress | 4 | 2014 | 1178 | 0.150 |
Why?
| Regulon | 3 | 2018 | 31 | 0.150 |
Why?
| Nucleotides | 1 | 2018 | 112 | 0.150 |
Why?
| Urinary Tract Infections | 1 | 1999 | 136 | 0.150 |
Why?
| Anaerobiosis | 3 | 2012 | 50 | 0.150 |
Why?
| Macrophage Activation | 6 | 2008 | 168 | 0.150 |
Why?
| Oxidoreductases | 1 | 2016 | 100 | 0.140 |
Why?
| B-Lymphocytes | 3 | 1999 | 770 | 0.140 |
Why?
| Candidiasis, Oral | 1 | 1995 | 18 | 0.130 |
Why?
| Candidiasis, Vulvovaginal | 1 | 1995 | 5 | 0.130 |
Why?
| Transcription Factors | 4 | 2018 | 1570 | 0.130 |
Why?
| Transforming Growth Factor beta | 3 | 2005 | 462 | 0.120 |
Why?
| Germ-Free Life | 4 | 1997 | 30 | 0.120 |
Why?
| Microbial Sensitivity Tests | 2 | 2012 | 302 | 0.120 |
Why?
| Reactive Oxygen Species | 4 | 2012 | 576 | 0.110 |
Why?
| Mice, Mutant Strains | 6 | 2007 | 280 | 0.110 |
Why?
| Neutrophils | 4 | 1999 | 1233 | 0.110 |
Why?
| Nitroso Compounds | 1 | 2012 | 6 | 0.110 |
Why?
| Melioidosis | 1 | 2012 | 4 | 0.110 |
Why?
| Membrane Glycoproteins | 3 | 2008 | 446 | 0.110 |
Why?
| Nitric Oxide Donors | 1 | 2012 | 16 | 0.110 |
Why?
| Spermine | 1 | 2012 | 28 | 0.110 |
Why?
| Superoxides | 4 | 2008 | 221 | 0.110 |
Why?
| Oxidants | 1 | 2012 | 122 | 0.110 |
Why?
| Receptors, Cell Surface | 2 | 2004 | 367 | 0.110 |
Why?
| Respiratory Burst | 3 | 2008 | 31 | 0.110 |
Why?
| Culture Media | 1 | 2012 | 163 | 0.100 |
Why?
| Alanine Racemase | 1 | 2011 | 2 | 0.100 |
Why?
| DNA-Binding Proteins | 2 | 2010 | 1346 | 0.100 |
Why?
| Glutathione | 1 | 2012 | 324 | 0.100 |
Why?
| Nitric Oxide Synthase Type II | 5 | 2013 | 165 | 0.100 |
Why?
| Sulfhydryl Compounds | 1 | 2012 | 179 | 0.100 |
Why?
| Hypoxia | 1 | 2016 | 963 | 0.090 |
Why?
| Virulence | 4 | 2020 | 240 | 0.090 |
Why?
| Cells, Cultured | 4 | 2014 | 4077 | 0.090 |
Why?
| Mice, Inbred BALB C | 6 | 2002 | 1206 | 0.090 |
Why?
| Disease Models, Animal | 4 | 2020 | 3730 | 0.080 |
Why?
| Nitric Oxide Synthase | 3 | 2000 | 225 | 0.080 |
Why?
| NADPH Dehydrogenase | 1 | 2008 | 8 | 0.080 |
Why?
| Spleen | 3 | 2000 | 510 | 0.080 |
Why?
| Peroxiredoxins | 1 | 2008 | 23 | 0.080 |
Why?
| Trans-Activators | 1 | 2010 | 373 | 0.080 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2005 | 1171 | 0.080 |
Why?
| Sphingomyelin Phosphodiesterase | 1 | 2007 | 26 | 0.080 |
Why?
| Nitrogen Oxides | 1 | 2007 | 56 | 0.080 |
Why?
| Lipopolysaccharides | 4 | 2005 | 870 | 0.070 |
Why?
| Organ Specificity | 1 | 2007 | 278 | 0.070 |
Why?
| Hydrogen Peroxide | 1 | 2008 | 305 | 0.070 |
Why?
| Survival Analysis | 2 | 2010 | 1267 | 0.070 |
Why?
| Genes, Bacterial | 4 | 2011 | 162 | 0.070 |
Why?
| Mutation | 4 | 2011 | 3457 | 0.070 |
Why?
| Anti-Infective Agents | 1 | 2008 | 227 | 0.060 |
Why?
| Models, Genetic | 1 | 2008 | 595 | 0.060 |
Why?
| Phagocytes | 2 | 2007 | 91 | 0.060 |
Why?
| Kupffer Cells | 1 | 2004 | 47 | 0.060 |
Why?
| Phagocytosis | 3 | 2004 | 364 | 0.060 |
Why?
| Leptin | 2 | 2004 | 231 | 0.050 |
Why?
| Stomach | 2 | 2000 | 103 | 0.050 |
Why?
| Molecular Sequence Data | 3 | 2011 | 2871 | 0.050 |
Why?
| Sigma Factor | 1 | 2002 | 33 | 0.050 |
Why?
| Colitis | 1 | 2004 | 219 | 0.050 |
Why?
| Disease Susceptibility | 2 | 2004 | 331 | 0.050 |
Why?
| Models, Biological | 1 | 2008 | 1715 | 0.050 |
Why?
| ADP Ribose Transferases | 1 | 2000 | 10 | 0.050 |
Why?
| Guanosine Pentaphosphate | 1 | 2020 | 3 | 0.050 |
Why?
| Hydroxides | 1 | 2000 | 26 | 0.050 |
Why?
| Cell Survival | 2 | 2020 | 1047 | 0.050 |
Why?
| Immunity, Cellular | 3 | 1999 | 270 | 0.050 |
Why?
| Colony Count, Microbial | 1 | 2000 | 120 | 0.050 |
Why?
| Liver | 4 | 2004 | 1816 | 0.050 |
Why?
| CD18 Antigens | 1 | 1999 | 35 | 0.050 |
Why?
| Gram-Positive Bacteria | 1 | 2020 | 47 | 0.050 |
Why?
| Mice, Inbred MRL lpr | 1 | 1999 | 39 | 0.040 |
Why?
| Gram-Negative Bacteria | 1 | 2020 | 70 | 0.040 |
Why?
| Transcription Factor RelA | 1 | 2020 | 82 | 0.040 |
Why?
| Gene Deletion | 2 | 2011 | 361 | 0.040 |
Why?
| Receptors, Interleukin | 1 | 1999 | 41 | 0.040 |
Why?
| Mucous Membrane | 1 | 2000 | 113 | 0.040 |
Why?
| Bacterial Toxins | 1 | 2000 | 106 | 0.040 |
Why?
| Intestinal Diseases | 1 | 1999 | 30 | 0.040 |
Why?
| Chemical and Drug Induced Liver Injury | 1 | 2000 | 136 | 0.040 |
Why?
| Type III Secretion Systems | 1 | 2018 | 9 | 0.040 |
Why?
| Interleukin-18 | 1 | 2000 | 228 | 0.040 |
Why?
| Humans | 6 | 2016 | 118974 | 0.040 |
Why?
| Esophagus | 1 | 2000 | 237 | 0.040 |
Why?
| Antioxidants | 1 | 2002 | 564 | 0.040 |
Why?
| Mice, Inbred C3H | 2 | 2010 | 250 | 0.040 |
Why?
| Antigens, Fungal | 1 | 1997 | 26 | 0.040 |
Why?
| Wound Healing | 1 | 1999 | 270 | 0.040 |
Why?
| beta 2-Microglobulin | 1 | 1996 | 47 | 0.040 |
Why?
| Interleukin-10 | 1 | 1999 | 306 | 0.040 |
Why?
| Antigens, CD | 1 | 1999 | 460 | 0.040 |
Why?
| Lymphocyte Activation | 2 | 1999 | 1067 | 0.040 |
Why?
| Mice, Nude | 2 | 1995 | 663 | 0.040 |
Why?
| Nitrates | 1 | 1996 | 78 | 0.040 |
Why?
| Intestines | 1 | 1999 | 332 | 0.040 |
Why?
| Immunophenotyping | 1 | 1997 | 278 | 0.040 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2000 | 632 | 0.030 |
Why?
| Amino Acid Oxidoreductases | 1 | 1995 | 21 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 2011 | 1012 | 0.030 |
Why?
| Antifungal Agents | 1 | 1996 | 134 | 0.030 |
Why?
| Specific Pathogen-Free Organisms | 1 | 1995 | 61 | 0.030 |
Why?
| Histocompatibility Antigens Class I | 1 | 1996 | 177 | 0.030 |
Why?
| Kidney | 2 | 2000 | 1353 | 0.030 |
Why?
| Recombinant Proteins | 2 | 1995 | 1308 | 0.030 |
Why?
| Lymphocyte Depletion | 1 | 1995 | 119 | 0.030 |
Why?
| NADPH Oxidase 2 | 2 | 2008 | 42 | 0.030 |
Why?
| Immunocompetence | 1 | 1994 | 43 | 0.030 |
Why?
| Cell Separation | 1 | 1995 | 296 | 0.030 |
Why?
| Arginine | 1 | 1995 | 249 | 0.030 |
Why?
| Analysis of Variance | 2 | 2013 | 1293 | 0.030 |
Why?
| Promoter Regions, Genetic | 1 | 2018 | 1158 | 0.030 |
Why?
| Nitrosation | 1 | 2012 | 10 | 0.030 |
Why?
| Reactive Nitrogen Species | 1 | 2012 | 25 | 0.030 |
Why?
| Molecular Weight | 1 | 2012 | 343 | 0.030 |
Why?
| Microscopy, Electron | 2 | 2005 | 413 | 0.030 |
Why?
| Gene Expression Profiling | 2 | 2011 | 1597 | 0.030 |
Why?
| Periodic Acid | 1 | 2011 | 1 | 0.030 |
Why?
| Flow Cytometry | 1 | 1995 | 1085 | 0.030 |
Why?
| Base Sequence | 1 | 1995 | 2159 | 0.020 |
Why?
| Alanine | 1 | 2011 | 102 | 0.020 |
Why?
| Microscopy, Fluorescence | 2 | 2005 | 412 | 0.020 |
Why?
| Microarray Analysis | 1 | 2011 | 124 | 0.020 |
Why?
| Operon | 1 | 2010 | 62 | 0.020 |
Why?
| Brain | 2 | 2000 | 2490 | 0.020 |
Why?
| Sequence Alignment | 1 | 2011 | 336 | 0.020 |
Why?
| Gene Knockout Techniques | 1 | 2010 | 105 | 0.020 |
Why?
| Chromatin Immunoprecipitation | 1 | 2010 | 136 | 0.020 |
Why?
| Plasmids | 1 | 2011 | 355 | 0.020 |
Why?
| Genetic Markers | 1 | 2011 | 348 | 0.020 |
Why?
| Metabolic Networks and Pathways | 1 | 2011 | 176 | 0.020 |
Why?
| Inflammation | 2 | 1999 | 2566 | 0.020 |
Why?
| Genetic Loci | 1 | 2011 | 281 | 0.020 |
Why?
| Mice, SCID | 2 | 2004 | 333 | 0.020 |
Why?
| Immunity | 1 | 2010 | 129 | 0.020 |
Why?
| DNA, Bacterial | 1 | 2010 | 314 | 0.020 |
Why?
| Time Factors | 1 | 2000 | 6412 | 0.020 |
Why?
| Peroxynitrous Acid | 1 | 2008 | 13 | 0.020 |
Why?
| Flavoproteins | 1 | 2007 | 7 | 0.020 |
Why?
| Hemeproteins | 1 | 2007 | 7 | 0.020 |
Why?
| Drug Resistance, Microbial | 1 | 2008 | 67 | 0.020 |
Why?
| Succinate Dehydrogenase | 1 | 2007 | 44 | 0.020 |
Why?
| Concanavalin A | 2 | 2000 | 74 | 0.020 |
Why?
| Gangliosides | 1 | 2007 | 19 | 0.020 |
Why?
| Apoptosis | 1 | 1997 | 2484 | 0.020 |
Why?
| Guanidines | 2 | 1999 | 37 | 0.020 |
Why?
| Host-Pathogen Interactions | 1 | 2010 | 300 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2011 | 2071 | 0.020 |
Why?
| Sphingolipids | 1 | 2007 | 62 | 0.020 |
Why?
| Cytosol | 1 | 2007 | 221 | 0.020 |
Why?
| Interleukin-4 | 2 | 1999 | 215 | 0.020 |
Why?
| Ceramides | 1 | 2007 | 104 | 0.020 |
Why?
| Antibody Formation | 2 | 1999 | 276 | 0.020 |
Why?
| Acute Disease | 2 | 1999 | 940 | 0.020 |
Why?
| Female | 7 | 2011 | 61565 | 0.020 |
Why?
| Escherichia coli Proteins | 1 | 2007 | 170 | 0.020 |
Why?
| DNA, Complementary | 1 | 2005 | 268 | 0.020 |
Why?
| Protein Binding | 1 | 2010 | 1975 | 0.020 |
Why?
| Mice, Congenic | 1 | 2004 | 23 | 0.020 |
Why?
| Lymphocyte Transfusion | 1 | 2004 | 19 | 0.020 |
Why?
| Intestinal Mucosa | 2 | 1999 | 531 | 0.020 |
Why?
| Receptors, Leptin | 1 | 2004 | 27 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 770 | 0.020 |
Why?
| Leukocyte Common Antigens | 1 | 2004 | 76 | 0.020 |
Why?
| RNA, Bacterial | 1 | 2005 | 175 | 0.020 |
Why?
| Chemokines, CXC | 1 | 2004 | 64 | 0.020 |
Why?
| Neutrophil Infiltration | 1 | 2004 | 97 | 0.020 |
Why?
| Cytotoxicity, Immunologic | 1 | 2004 | 204 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2011 | 2874 | 0.010 |
Why?
| Th1 Cells | 1 | 2004 | 133 | 0.010 |
Why?
| Toll-Like Receptors | 1 | 2004 | 167 | 0.010 |
Why?
| Corticosterone | 1 | 2004 | 253 | 0.010 |
Why?
| Aerobiosis | 1 | 2002 | 21 | 0.010 |
Why?
| Toll-Like Receptor 4 | 1 | 2004 | 330 | 0.010 |
Why?
| Exotoxins | 1 | 2000 | 15 | 0.010 |
Why?
| Cerium | 1 | 2000 | 12 | 0.010 |
Why?
| Vacuoles | 1 | 2000 | 33 | 0.010 |
Why?
| Peroxides | 1 | 2000 | 21 | 0.010 |
Why?
| Mice, Obese | 1 | 2000 | 58 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2000 | 155 | 0.010 |
Why?
| 3-Phosphoshikimate 1-Carboxyvinyltransferase | 1 | 1999 | 4 | 0.010 |
Why?
| Cell Division | 1 | 2002 | 776 | 0.010 |
Why?
| Luminol | 1 | 1999 | 1 | 0.010 |
Why?
| Receptors, Interleukin-8A | 1 | 1999 | 6 | 0.010 |
Why?
| Alkyl and Aryl Transferases | 1 | 1999 | 33 | 0.010 |
Why?
| Fimbriae, Bacterial | 1 | 1999 | 26 | 0.010 |
Why?
| Transplantation Chimera | 1 | 1999 | 51 | 0.010 |
Why?
| Tyrosine | 1 | 2000 | 233 | 0.010 |
Why?
| Indicators and Reagents | 1 | 1999 | 100 | 0.010 |
Why?
| Lymphocyte Cooperation | 1 | 1999 | 50 | 0.010 |
Why?
| Injections, Intravenous | 1 | 1999 | 210 | 0.010 |
Why?
| Transplantation Immunology | 1 | 1999 | 31 | 0.010 |
Why?
| Mutagenesis | 1 | 1999 | 176 | 0.010 |
Why?
| Luminescent Measurements | 1 | 1999 | 72 | 0.010 |
Why?
| Biological Transport | 1 | 1999 | 382 | 0.010 |
Why?
| Bone Marrow Transplantation | 1 | 1999 | 244 | 0.010 |
Why?
| Chronic Disease | 1 | 2004 | 1636 | 0.010 |
Why?
| Major Histocompatibility Complex | 1 | 1999 | 220 | 0.010 |
Why?
| Bacteremia | 1 | 1999 | 161 | 0.010 |
Why?
| Stomach Ulcer | 1 | 1997 | 9 | 0.010 |
Why?
| Ulcer | 1 | 1997 | 28 | 0.010 |
Why?
| Disease Progression | 1 | 2004 | 2490 | 0.010 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 1999 | 613 | 0.010 |
Why?
| Glucans | 1 | 1996 | 25 | 0.010 |
Why?
| Hyperplasia | 1 | 1997 | 170 | 0.010 |
Why?
| Immune Tolerance | 1 | 1999 | 334 | 0.010 |
Why?
| Opsonin Proteins | 1 | 1996 | 26 | 0.010 |
Why?
| Digestive System Diseases | 1 | 1996 | 27 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1997 | 405 | 0.010 |
Why?
| Male | 5 | 2004 | 57801 | 0.010 |
Why?
| Hematopoietic Stem Cells | 1 | 1999 | 359 | 0.010 |
Why?
| Cytokines | 1 | 2004 | 1900 | 0.010 |
Why?
| Inflammation Mediators | 1 | 1999 | 502 | 0.010 |
Why?
| Longevity | 1 | 1997 | 151 | 0.010 |
Why?
| Killer Cells, Natural | 1 | 1999 | 381 | 0.010 |
Why?
| omega-N-Methylarginine | 1 | 1995 | 27 | 0.010 |
Why?
| Infusions, Intravenous | 1 | 1996 | 380 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2004 | 2275 | 0.010 |
Why?
| Nitroprusside | 1 | 1995 | 88 | 0.010 |
Why?
| Homeostasis | 1 | 1999 | 594 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 1999 | 827 | 0.010 |
Why?
| Nitrites | 1 | 1995 | 81 | 0.010 |
Why?
| Thioglycolates | 1 | 1994 | 3 | 0.010 |
Why?
| Genotype | 1 | 1999 | 1882 | 0.010 |
Why?
| Pneumonia | 1 | 1999 | 592 | 0.010 |
Why?
| Chemotaxis | 1 | 1994 | 137 | 0.010 |
Why?
| Blotting, Western | 1 | 1996 | 1194 | 0.010 |
Why?
| Superoxide Dismutase | 1 | 1994 | 339 | 0.010 |
Why?
| Hot Temperature | 1 | 1994 | 334 | 0.010 |
Why?
| Signal Transduction | 1 | 2004 | 4709 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 1995 | 1945 | 0.010 |
Why?
| Aging | 1 | 1999 | 1670 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 1996 | 2445 | 0.000 |
Why?
|
|
Jones-Carson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|